Hangzhou Tigermed Consulting Co., Ltd. (3347.HK) HKSE

Currency In HKD

AD

Hangzhou Tigermed Consulting Co., Ltd.

Address

F18, Building A – Shengda Science Park

Hangzhou, 310051

China

Phone

86 57 1288 87227

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Employees

10185

First IPO Date

August 07, 2020

Key Executives

NameTitlePayYear Born
Xiaochun CaoCo-Founder, GM & Executive Director1M1969
Hao WuCo- President & Executive Director2.05M1967
Zengyu WenCo-President, Executive VP, COO & Executive Director2.7M1980
Xiaoping Ye D.Phil EMBACo-Founder & Chairman3.32M1963
Xiao Li ShiVice President & Head of Data Resources Department01971
Yun Jie GongSenior VP & Chief Quality Officer0N/A
Jiansong YangSenior Vice President & Chief Scientific Officer0N/A
Yanhong ChenVP, Head of Global Project Mgmt & GM of TigerMed Australia0N/A
Xia ChenSenior VP & Chief Medical Officer0N/A
Chengcheng YangChief Financial Officer01974
Tianrong JiChief Investment Officer0N/A
Mei Yee Yung FCISCompany Secretary01965
Xiao Ri LiSecretary01983
Mo ShuangChief Compliance Officer0N/A
AD

Description

Hangzhou Tigermed Consulting Co., Ltd. operates as a contract research organization (CRO) across the People's Republic of China and globally, offering an extensive suite of services. The company's operations are divided into two primary segments: Clinical Trial Solutions and Clinical-related and Laboratory Services. Its service portfolio includes support for regulatory submissions and approvals, medical translation, and Good Manufacturing Practice (GMP) consulting. Tigermed provides comprehensive clinical services, addressing areas such as medical science, early-phase and late-phase clinical development, medical monitoring, project management, patient enrollment, and quality management systems. Biometrics services encompass data management, biostatistics, and statistical programming. Moreover, the company delivers integrated technology solutions, featuring site management, pharmacovigilance, independent audit and training programs, medical imaging, clinical trial system development, central laboratory functions, pre-clinical investigations, and research hospital support. For medical devices and in vitro diagnostics (IVD), Tigermed offers specialized services like product testing, regulatory submissions, clinical evaluations and trials, GMP certification, EU MDR and IVDR readiness, and supplementary value-added services. Its expertise also extends to post-marketing studies, real-world evidence generation, and clinical trials for vaccines. Hangzhou Tigermed Consulting Co., Ltd. was established in 2004 and is headquartered in Hangzhou, PRC.

AD